{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:44:24Z","timestamp":1764906264198,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction\/Objectives<\/jats:title>\n                <jats:p>Optic nerve sheath (ONS) enhancement using magnetic resonance imaging of the orbits was observed in patients with giant cell arteritis (GCA). We previously showed that ONS diameter (ONSD) by bedside ultrasound is increased in patient with active GCA. This study aims to assess whether ONSD decreases with clinical remission in patients with GCA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective cohort study was conducted from June 2022 to January 2023. Patients who had an optic nerve ultrasound at GCA diagnosis as part of a previous crosssectional study were eligible. Optic nerve ultrasound was performed by the same investigator at diagnosis and month 3. ONSD (includes the optic nerve and its sheath) and optic nerve diameter (OND) were measured. Descriptive statistics for baseline characteristics and paired sample t-test were performed to assess the mean difference in OND and ONSD between diagnosis and month 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Nine patients with GCA were included. The median age at disease onset was 79\u00a0years (interquartile range (IQR) of 79\u201382\u00a0years), and 7 patients were males. All patients were in clinical remission at month 3 on prednisone (median dose of 15\u00a0mg\/day, IQR of 10\u201325\u00a0mg). The mean ONSD was lower at month 3 (3.76\u00a0mm) compared to baseline (5.98\u00a0mm), with a paired mean difference of 2.22\u00a0mm (95% CI 1.41\u20133.03\u00a0mm, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). As anticipated, OND measurements did not vary between diagnosis and month 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ONSD on ultrasound improves after 3 months of therapy in patients with GCA. A longer prospective study is required to determine if ONSD is useful to assess disease activity in GCA.\n<jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td align=\"left\"><jats:bold>Key Points<\/jats:bold><\/jats:td>\n                      <\/jats:tr>\n                      <jats:tr>\n                        <jats:td align=\"left\">\u2022 <jats:italic>ONS ultrasound can identify patients with active GCA.<\/jats:italic>\u2022 <jats:italic>The ONSD on ultrasound is dynamic and improved after 3\u00a0months of GCA therapy.<\/jats:italic>\u2022 <jats:italic>ONS ultrasound may be useful to monitor disease activity in GCA.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-024-07095-z","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:02:00Z","timestamp":1723042920000},"page":"3205-3212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optic nerve sheath measurement to monitor disease activity in giant cell arteritis: a pilot study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-3245","authenticated-orcid":false,"given":"Carolyn","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-3815","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Ducharme-B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-7448","authenticated-orcid":false,"given":"Samer","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1383-6957","authenticated-orcid":false,"given":"Rosalie-S\u00e9l\u00e8ne","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-9549","authenticated-orcid":false,"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4523-8525","authenticated-orcid":false,"given":"Jean-Paul","family":"Makhzoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"7095_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"7095_CR2","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00330-022-09256-7","volume":"33","author":"KV Guggenberger","year":"2023","unstructured":"Guggenberger KV, Vogt ML, Song JW, Weng AM, Frohlich M, Schmalzing M et al (2023) Intraorbital findings in giant cell arteritis on black blood MRI. Eur Radiol 33:2529\u20132535. https:\/\/doi.org\/10.1007\/s00330-022-09256-7","journal-title":"Eur Radiol"},{"key":"7095_CR3","doi-asserted-by":"publisher","first-page":"e937565","DOI":"10.12659\/AJCR.937565","volume":"23","author":"DS Jalaledin","year":"2022","unstructured":"Jalaledin DS, Ross C, Makhzoum JP (2022) Rare ischemic complications of giant cell arteritis: case series and literature review. Am J Case Rep 23:e937565. https:\/\/doi.org\/10.12659\/AJCR.937565","journal-title":"Am J Case Rep"},{"key":"7095_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMc1509058","volume":"373","author":"V Biousse","year":"2015","unstructured":"Biousse V, Newman NJ (2015) Ischemic optic neuropathies. N Engl J Med 373:1677. https:\/\/doi.org\/10.1056\/NEJMc1509058","journal-title":"N Engl J Med"},{"key":"7095_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/art.41774","volume":"73","author":"M Maz","year":"2021","unstructured":"Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G et al (2021) 2021 American College of Rheumatology\/Vasculitis foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis Rheumatol 73:1349\u20131365. https:\/\/doi.org\/10.1002\/art.41774","journal-title":"Arthritis Rheumatol"},{"key":"7095_CR6","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3899\/jrheum.141347","volume":"42","author":"TA Kermani","year":"2015","unstructured":"Kermani TA, Warrington KJ, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA et al (2015) Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study. J Rheumatol 42:1213\u20131217. https:\/\/doi.org\/10.3899\/jrheum.141347","journal-title":"J Rheumatol"},{"key":"7095_CR7","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1056\/NEJMc1711031","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Klearman M, Collinson N (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377:1494\u20131495. https:\/\/doi.org\/10.1056\/NEJMc1711031","journal-title":"N Engl J Med"},{"key":"7095_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11926-021-00980-5","volume":"23","author":"E Tombetti","year":"2021","unstructured":"Tombetti E, Hysa E, Mason JC, Cimmino MA, Camellino D (2021) Blood biomarkers for monitoring and prognosis of large vessel vasculitides. Curr Rheumatol Rep 23:17. https:\/\/doi.org\/10.1007\/s11926-021-00980-5","journal-title":"Curr Rheumatol Rep"},{"key":"7095_CR9","doi-asserted-by":"publisher","first-page":"rkab083","DOI":"10.1093\/rap\/rkab083","volume":"5","author":"F Zarka","year":"2021","unstructured":"Zarka F, Rheaume M, Belhocine M, Goulet M, Febrer G, Mansour AM et al (2021) Colour Doppler ultrasound and the giant cell arteritis probability score for the diagnosis of giant cell arteritis: a Canadian single-centre experience. Rheumatol Adv Pract 5:rkab083. https:\/\/doi.org\/10.1093\/rap\/rkab083","journal-title":"Rheumatol Adv Pract"},{"key":"7095_CR10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","volume":"337","author":"WA Schmidt","year":"1997","unstructured":"Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336\u20131342. https:\/\/doi.org\/10.1056\/NEJM199711063371902","journal-title":"N Engl J Med"},{"key":"7095_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20900","volume":"20","author":"R Luqmani","year":"2016","unstructured":"Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M et al (2016) The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20:1\u2013238. https:\/\/doi.org\/10.3310\/hta20900","journal-title":"Health Technol Assess"},{"key":"7095_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/eye.2016.19","volume":"30","author":"NM D\u2019Souza","year":"2016","unstructured":"D\u2019Souza NM, Morgan ML, Almarzouqi SJ, Lee AG (2016) Magnetic resonance imaging findings in giant cell arteritis. Eye (Lond) 30:758\u2013762. https:\/\/doi.org\/10.1038\/eye.2016.19","journal-title":"Eye (Lond)"},{"key":"7095_CR13","doi-asserted-by":"publisher","first-page":"16553","DOI":"10.1038\/s41598-022-20916-y","volume":"12","author":"LA Danyel","year":"2022","unstructured":"Danyel LA, Miszczuk M, Pietrock C, Buge BT, Villringer K, Bohner G, Siebert E (2022) Utility of standard diffusion-weighted magnetic resonance imaging for the identification of ischemic optic neuropathy in giant cell arteritis. Sci Rep 12:16553. https:\/\/doi.org\/10.1038\/s41598-022-20916-y","journal-title":"Sci Rep"},{"key":"7095_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/WNO.0000000000000860","volume":"41","author":"SM Gospe 3rd","year":"2021","unstructured":"Gospe SM 3rd, Amrhein TJ, Malinzak MD, Bhatti MT, Mettu P, El-Dairi MA (2021) Magnetic resonance imaging abnormalities of the optic nerve sheath and intracranial internal carotid artery in giant cell arteritis. J Neuroophthalmol 41:54\u201359. https:\/\/doi.org\/10.1097\/WNO.0000000000000860","journal-title":"J Neuroophthalmol"},{"key":"7095_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/WNO.0b013e3182915b77","volume":"33","author":"KC Liu","year":"2013","unstructured":"Liu KC, Chesnutt DA (2013) Perineural optic nerve enhancement on magnetic resonance imaging in giant cell arteritis. J Neuroophthalmol 33:279\u2013281. https:\/\/doi.org\/10.1097\/WNO.0b013e3182915b77","journal-title":"J Neuroophthalmol"},{"key":"7095_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s004170100310","volume":"239","author":"AG Lee","year":"2001","unstructured":"Lee AG, Tang RA, Feldon SE, Pless M, Schiffman JS, Rubin RM, Rao N (2001) Orbital presentations of giant cell arteritis. Graefes Arch Clin Exp Ophthalmol 239:509\u2013513. https:\/\/doi.org\/10.1007\/s004170100310","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7095_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/rheumatology\/kep011","volume":"48","author":"J Geiger","year":"2009","unstructured":"Geiger J, Ness T, Uhl M, Lagreze WA, Vaith P, Langer M, Bley TA (2009) Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology (Oxford) 48:537\u2013541. https:\/\/doi.org\/10.1093\/rheumatology\/kep011","journal-title":"Rheumatology (Oxford)"},{"key":"7095_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/RLI.0000000000000500","volume":"53","author":"NN Sommer","year":"2018","unstructured":"Sommer NN, Treitl KM, Coppenrath E, Kooijman H, Dechant C, Czihal M et al (2018) Three-dimensional high-resolution black-blood magnetic resonance imaging for detection of arteritic anterior ischemic optic neuropathy in patients with giant cell arteritis. Invest Radiol 53:698\u2013704. https:\/\/doi.org\/10.1097\/RLI.0000000000000500","journal-title":"Invest Radiol"},{"key":"7095_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/01658107.2022.2099427","volume":"47","author":"Y Yan","year":"2023","unstructured":"Yan Y, Li Z, Luo Y, Chen P, Liu L (2023) Biopsy-proven giant cell arteritis associated vision loss in chinese subjects: a case series and review of the literature. Neuroophthalmology 47:79\u201387. https:\/\/doi.org\/10.1080\/01658107.2022.2099427","journal-title":"Neuroophthalmology"},{"key":"7095_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11729","author":"H Baalbaki","year":"2024","unstructured":"Baalbaki H, Dube D, Ross C, Ducharme-Benard S, Hussein S, Meunier RS et al (2024) Optic nerve sheath measurement on ultrasound: a novel diagnostic test for giant cell arteritis. ACR Open Rheumatol. https:\/\/doi.org\/10.1002\/acr2.11729","journal-title":"ACR Open Rheumatol"},{"key":"7095_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/WNO.0b013e318183c4bb","volume":"28","author":"S Erdogmus","year":"2008","unstructured":"Erdogmus S, Govsa F (2008) Anatomic characteristics of the ophthalmic and posterior ciliary arteries. J Neuroophthalmol 28:320\u2013324. https:\/\/doi.org\/10.1097\/WNO.0b013e318183c4bb","journal-title":"J Neuroophthalmol"},{"key":"7095_CR22","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A et al (2022) 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81:1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"7095_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10067-023-06721-6","volume":"43","author":"C Sargi","year":"2024","unstructured":"Sargi C, Ducharme-Benard S, Benard V, Meunier RS, Ross C, Makhzoum JP (2024) Assessment and comparison of probability scores to predict giant cell arteritis. Clin Rheumatol 43:357\u2013365. https:\/\/doi.org\/10.1007\/s10067-023-06721-6","journal-title":"Clin Rheumatol"},{"key":"7095_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamaophthalmol.2017.6560","volume":"136","author":"LJ Wang","year":"2018","unstructured":"Wang LJ, Chen LM, Chen Y, Bao LY, Zheng NN, Wang YZ, Xing YQ (2018) Ultrasonography assessments of optic nerve sheath diameter as a noninvasive and dynamic method of detecting changes in intracranial pressure. JAMA Ophthalmol 136:250\u2013256. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.6560","journal-title":"JAMA Ophthalmol"},{"key":"7095_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3980\/j.issn.2222-3959.2015.06.30","volume":"8","author":"M Vaiman","year":"2015","unstructured":"Vaiman M, Abuita R, Bekerman I (2015) Optic nerve sheath diameters in healthy adults measured by computer tomography. Int J Ophthalmol 8:1240\u20131244. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2015.06.30","journal-title":"Int J Ophthalmol"},{"key":"7095_CR26","doi-asserted-by":"publisher","first-page":"845554","DOI":"10.3389\/fmed.2022.845554","volume":"9","author":"M De Bernardo","year":"2022","unstructured":"De Bernardo M, Vitiello L, De Pascale I, Capasso L, Cornetta P, Rosa N (2022) Optic nerve ultrasound evaluation in idiopathic intracranial hypertension. Front Med (Lausanne) 9:845554. https:\/\/doi.org\/10.3389\/fmed.2022.845554","journal-title":"Front Med (Lausanne)"},{"key":"7095_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12883-023-03062-4","volume":"23","author":"G Trocha","year":"2023","unstructured":"Trocha G, Bonilla A, Romero C, Palacios J, Molano-Gonzalez N (2023) Ultrasound measurement of optic nerve sheath diameter in a healthy adult Colombian population. BMC Neurol 23:16. https:\/\/doi.org\/10.1186\/s12883-023-03062-4","journal-title":"BMC Neurol"},{"key":"7095_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fneur.2020.00764","volume":"11","author":"D Cardim","year":"2020","unstructured":"Cardim D, Czosnyka M, Chandrapatham K, Badenes R, Bertuccio A, Noto AD et al (2020) Effects of age and sex on optic nerve sheath diameter in healthy volunteers and patients with traumatic brain injury. Front Neurol 11:764. https:\/\/doi.org\/10.3389\/fneur.2020.00764","journal-title":"Front Neurol"},{"key":"7095_CR29","unstructured":"Rhee RBS, Bhatt V, Tamhankar M, Cao Q, Amudala N, Chou S, Burke M, Loevner L, Merkel P, Song J (2022) Combined orbital and cranial vessel wall mri for diagnosis and longitudinal monitoring of giant cell arteritis (abstract). Arthritis Rheumatol 74(suppl 9). https:\/\/acrabstracts.org\/abstract\/combined-orbital-and-cranial-vesselwall-mri-for-diagnosis-and-longitudinal-monitoring-of-giant-cell-arteritis\/"},{"key":"7095_CR30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/art.40044","volume":"69","author":"CA Langford","year":"2017","unstructured":"Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S et al (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheumatol 69:837\u2013845. https:\/\/doi.org\/10.1002\/art.40044","journal-title":"Arthritis Rheumatol"},{"key":"7095_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s13063-021-05520-1","volume":"22","author":"N Venhoff","year":"2021","unstructured":"Venhoff N, Schmidt WA, Lamprecht P, Tony HP, App C, Sieder C et al (2021) Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial. Trials 22:543. https:\/\/doi.org\/10.1186\/s13063-021-05520-1","journal-title":"Trials"},{"key":"7095_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13089-016-0053-9","volume":"8","author":"GG Johnson","year":"2016","unstructured":"Johnson GG, Zeiler FA, Unger B, Hansen G, Karakitsos D, Gillman LM (2016) Estimating the accuracy of optic nerve sheath diameter measurement using a pocket-sized, handheld ultrasound on a simulation model. Crit Ultrasound J 8:18. https:\/\/doi.org\/10.1186\/s13089-016-0053-9","journal-title":"Crit Ultrasound J"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07095-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:06:50Z","timestamp":1727672810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07095-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7095"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07095-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by our institution\u2019s research ethics board (protocol number 20201890, Sacre-Coeur Hospital, Montreal, Quebec, Canada). All patients consented to be enrolled in this study and provided informed signed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Dr. Ross has received consultation fees from Otsuka\u00ae outside the submitted work. Dr. Ducharme-B\u00e9nard has received presentation and focus group fees from Novartis\u00ae outside the submitted work. Dr. Hussein has received presentation fees from Janssen\u00ae and is an investigator in clinical trials funded by Astra-Zeneca outside the submitted work. Dr. Pagnoux has received consultation or presentation fees from Roche\u00ae, Otsuka\u00ae, GlaxoSmithKline\u00ae, Astra-Zeneca\u00ae, Sanofi \u00ae, BMS\u00ae, and ChemoCentryx\u00ae and has received research funds from CanVasc, the Vasculitis Clinical Research Consortium (VCRC), GSK\u00ae, Astra-Zeneca\u00ae, and Otsuka\u00ae outside the submitted work. Dr. Makhzoum has received consultation or presentation fees from Roche\u00ae, Otsuka\u00ae, GlaxoSmithKline\u00ae, Astra-Zeneca\u00ae, and Sanofi \u00ae and is an investigator in clinical trials funded by Health Canada, the Vasculitis Clinical Research Consortium (VCRC), Janssen\u00ae, and Novartis\u00ae outside the submitted work. All other authors had no conflicts of interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}